Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning with FDA, ICH, and ISO standards, ...

Market opportunities arise in providing solutions for cGMP software verification and validation, addressing increased FDA scrutiny. Demand exists for expertise in FDA guidelines, risk management ...

WEST SACRAMENTO, Calif., March 28, 2023 /PRNewswire/ -- Gemini Bioproducts, LLC ("GeminiBio"), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids for the biotech ...

The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ...

Industry practice has changed radically over the past five decades. Can laws published in the 1960s still ensure pharmaceutical quality and safety today? In the pharmaceutical industry, it often takes ...

TUSTIN, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to ...

PLANTATION, Fla., Nov. 14, 2018 /PRNewswire/ -- Radimmune Therapeutics has selected Goodwin Biotechnology, Inc. to develop a process and manufacture it's lead therapeutic oncology candidate for ...

Our Cell Processing Facility (CPF) is a Good Manufacturing Practice, or GMP, bioprocessing manufacturing facility that supports the reproducible production of human hematopoietic or immune-competent ...

BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (NORD) (“Nordicus” or the “Company”), a financial consulting ...